Top Story

Omeros reports $18.7 million net loss in first quarter

May 27, 2015

Omeros reported a net loss of $18.7 million, or $0.51 per share, in the first quarter 2015 vs. a net loss of $16.6 million, or $0.54 per share, in the first quarter 2014, according to a press release.

The company had a controlled launch of Omidria (1% phenylephrine and 0.3% ketorolac injection) in the first quarter, which resulted in product revenue of $238,000. Grant revenue was $150,000 compared with $100,000 in the first quarter 2014.

Publication Exclusive: Gore-Tex suture can be used in small-incision scleral fixation of hydrophilic acrylic IOL

May 27, 2015
Secondary IOL placement is often associated with an IOL exchange due to previous IOL subluxation or dislocation and, less commonly, aphakic correction. The location of…
Business News

Eylea US net sales increase 51% in first quarter

May 26, 2015
Eylea net sales in the U.S. increased 51% to $541 million in the first quarter of 2015 from $359 million in the first quarter of 2014, according to a press release from…
BLOG: Tightening revenue cycle management, part 3 Blog

BLOG: Tightening revenue cycle management, part 3

May 26, 2015
In this last of a three-part series on monitoring your practice’s billing department, I present three simple graphs that can be readily generated in Excel.The…
Noel Alpins In the JournalsPerspective

Cassini topographer shows parity with other devices

May 26, 2015
A novel keratometer with colored light-emitting diodes generated cylinder measurements comparable to those obtained with Placido rings, monochromatic LEDs and…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »
CME
Gaining Insight to Optimize Patient Outcomes: What Can We Do to Improve Postoperative Inflammation and Pain?

Gaining Insight to Optimize Patient Outcomes: What Can We Do to Improve Postoperative Inflammation and Pain?

This activity is supported by an educational grant from Bausch + Lomb.

Postoperative pain and inflammation can result as a consequence of cataract surgery despite advances in surgical…
More »
Meeting News Coverage Video
VIDEO: Update on microinvasive glaucoma procedures

VIDEO: Update on microinvasive glaucoma procedures

May 24, 2015
MILAN — At the OSN Italy meeting, E. Randy Craven, MD, talks about microinvasive glaucoma procedures, specifically…
More »